Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease
Cell Reports · 2025-03 · 44 (3) · 115355
DOI: 10.1016/j.celrep.2025.115355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-03. Verfasst von Thomas P Spargo und 26 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Genomics Research, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Haploinsufficiency, Genetic Predisposition to Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Intramural NIH HHS, NIH HHS.
Abstract (Originalsprache)
Despite its significant heritability, the genetic basis of Parkinson's disease (PD) remains incompletely understood. Here, in analyzing whole-genome sequence data from 3,809 PD cases and 247,101 controls in the UK Biobank, we discover that protein-truncating variants in ITSN1 confer a substantially increased risk of PD (p = 6.1 × 10-7; odds ratio [95% confidence interval] = 10.5 [5.2, 21.3]). We replicate this association in three independent datasets totaling 8,407 cases and 413,432 controls (combined p = 4.5 × 10-12). Notably, ITSN1 haploinsufficiency has also been associated with autism spectrum disorder, suggesting variable penetrance/expressivity. In Drosophila, we find that loss of the ITSN1 ortholog Dap160 exacerbates α-synuclein-induced neuronal toxicity and motor deficits, and in vitro assays further suggest a physical interaction between ITSN1 and α-synuclein. These results firmly establish ITSN1 as a PD risk gene with an effect size exceeding previously established loci, implicate vesicular trafficking dysfunction in PD pathogenesis, and potentially open new avenues for therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Genomics Research, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; Genetics & Genomics Graduate Program, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institut…
- Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., Suite N.1150, Houston, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., Suite N.1150, Houston, TX, USA.
- Department of Bioengineering, George R. Brown School of Engineering, Rice University, Houston, TX, USA.
- Quantitative and Computational Biology Graduate Program, Baylor College of Medicine, Houston, TX, USA.
Förderung
- NIGMS NIH HHS
- Intramural NIH HHS
- NIH HHS
- Wellcome Trust
- Howard Hughes Medical Institute
- Huffington Foundation
- National Institutes of Health Office of the Director
Zitieren
APA
Spargo, T. P., Sands, C. F., Juan, I. R., Mitchell, J., Ravanmehr, V., Butts, J. C., De-Paula, R. B., Kim, Y., Hu, F., Wang, Q., Vitsios, D., Garg, M., Middleton, L., Tyrlik, M., Messa, M., Del Angel, G., Calame, D. G., Saade, H., Robak, L., …, & Dhindsa, R. S. (2025). Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease. Cell Reports, 44(3), 115355. https://doi.org/10.1016/j.celrep.2025.115355
Vancouver
Spargo TP, Sands CF, Juan IR, Mitchell J, Ravanmehr V, Butts JC, et al. Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease. Cell Reports. 2025;44(3):115355. doi:10.1016/j.celrep.2025.115355
BibTeX
@article{Spargo2025,
author = {Spargo, Thomas P and Sands, Chloe F and Juan, Isabella R and Mitchell, Jonathan and Ravanmehr, Vida and Butts, Jessica C and De-Paula, Ruth B and Kim, Youngdoo and Hu, Fengyuan and Wang, Quanli and Vitsios, Dimitrios and Garg, Manik and Middleton, Lawrence and Tyrlik, Michal and Messa, Mirko and Del Angel, Guillermo and Calame, Daniel G and Saade, Hiba and Robak, Laurie and Hollis, Ben and Cuddapah, Vishnu A and Zoghbi, Huda Y and Shulman, Joshua M and Petrovski, Slavé and Al-Ramahi, Ismael and Tachmazidou, Ioanna and Dhindsa, Ryan S},
title = {Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {3},
pages = {115355},
doi = {10.1016/j.celrep.2025.115355}
}
EUVIMED